The Latest Breaking News from Humana

While the stock market has entered a bear phase following the release of multi-decade high inflation data, the health insurance industry could survive the downturn because of the near-inelastic demand for health coverage. Therefore, investors looking to dodge a market downturn could bet on fundamentally sound health insurance stocks Anthem…

Humana (NYSE:HUM) has outperformed the market over the past 20 years by 10.8% on an annualized basis producing an average annual return of 17.56%. Currently, Humana has a market capitalization of $53.98 billion.

The health-care sector constitutes 'our favorite overweight for today's macro environment,' Bank of America analysts said.

Humana's (NYSE:HUM) short percent of float has risen 6.25% since its last report. The company recently reported that it has 1.50 million shares sold short, which is 1.19% of all regular shares that are available for trading.

US stocks closed sharply higher on Wednesday after the Federal Reserve raised its target fed funds rate by 0.5%. Investors, meanwhile, focused on some notable insider trades.

Something strange happened between the time Linda Griffith signed up for a new Medicare prescription drug plan during last fall’s enrollment period and when she tried to fill her first prescription in January.

Even the savviest Medicare drug plan shoppers can get a shock when they fill prescriptions: That great deal on medications in fall is no bargain after prices go up as much as 8% by winter.

Humana (NYSE:HUM) has outperformed the market over the past 20 years by 10.96% on an annualized basis producing an average annual return of 17.93%. Currently, Humana has a market capitalization of $54.86 billion.

Exxon Mobil and General Dynamics are among five stocks near buy points from strong groups that have already reported earnings.

Over the past 3 months, 6 analysts have published their opinion on Humana (NYSE:HUM) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

According to Benzinga Pro, during Q1, Humana (NYSE:HUM) earned $930.00 million, a 7253.85% increase from the preceding quarter. Humana also posted a total of $24.08 billion in sales, a 13.59% increase since Q4.